Showing 2001-2010 of 3134 results for "".
- Systematic Review Examines Hematoma Reduction Techniques in Faceliftshttps://modernaesthetics.com/news/systematic-review-examines-hematoma-reduction-techniques-in-facelifts/2484473/A new systematic review and meta-analysis published in Facial Plastic Surgery & Aesthetic Medicine underscores the incidence of hematoma after rhytidectomy and evaluates commonly used adjunctive techniques aimed at reducing this complication. The analysis focused on patients undergoi
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- VISTA Trial Validates Noninvasive Tool for Skin Feature Identificationhttps://modernaesthetics.com/news/vista-trial-validates-noninvasive-tool-for-skin-feature-identification/2484391/A novel imaging system may offer dermatologists a noninvasive alternative to assess histologic skin features, according to results from the VISTA Trial published in JAMA Dermatology. The multisite trial evaluated Enspectra Health’s VIO handheld cross-modal imaging system, which in
- FDA Warns Websites Selling Unapproved Botulinum Toxin Productshttps://modernaesthetics.com/news/fda-warns-websites-selling-unapproved-botulinum-toxin-products/2484341/The US Food and Drug Administration (FDA) has issued 18 warning letters to website operators illegally marketing unapproved and misbranded botulinum toxin products for cosmetic and medical use. The enforcement action follows reports of adverse events, including sym
- FDA Clears Ultherapy PRIME for Skin Laxity on Arms, Abdomenhttps://modernaesthetics.com/news/fda-clears-ultherapy-prime-for-skin-laxity-on-arms-abdomen/2484325/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME for the treatment of skin laxity on the anterior arms, posterior arms, and abdomen, according to Merz Aesthetics. The device is now FDA-cleared for noninvasive lifting and firming of the face, neck, décolleté, and body.
- FDA Approves Restylane Lyft for Chin Augmentation in Adultshttps://modernaesthetics.com/news/fda-approves-restylane-lyft-for-chin-augmentation-in-adults/2484326/Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Restylane® Lyft™ with Lidocaine for chin augmentation in adults over 21 with mild-to-moderate chin retrusion.
- Dermal Repair Complex Wins 2025 Nourish Award for Beauty and Collagen Supplementhttps://modernaesthetics.com/news/dermal-repair-complex-wins-2025-nourish-award-for-beauty-and-collagen-supplement/2484256/Beverly Hills MD Dermal Repair Complex has received the 2025 Nourish Award in the Beauty and Collagen category, according to a company announcement. The supplement, developed by cosmetic surgeons John Layke, DO, and Payman Danielpour, MD, is marketed as a skin-focused nutritional product formulat
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://modernaesthetics.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- BIOCORNEUM® Expands Product Line With New Bruise, Scar Recovery Solutionshttps://modernaesthetics.com/news/biocorneum-expands-product-line-with-new-bruise-scar-recovery-solutions/2484030/BIOCORNEUM® unveiled new additions to its recovery line during Plastic Surgery The Meeting, held October 9–12 in New Orleans. The brand introduced its new Bruise Care System, featuring a topical cream and an oral supplement designed for patients und
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://modernaesthetics.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni